Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:14 am
Author: Getaka|Social: XLinkedIn

Laurus Labs Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹395.85Overvalued by 61.90%vs CMP ₹1,039.00

P/E (70.0) × ROE (7.8%) × BV (₹91.10) × DY (0.12%)

₹221.28Overvalued by 78.70%vs CMP ₹1,039.00
MoS: -369.5% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹400.7222%Over (-61.4%)
Graham NumberEarnings₹174.4116%Over (-83.2%)
Earnings PowerEarnings₹30.7011%Over (-97%)
DCFCash Flow₹137.9813%Over (-86.7%)
Net Asset ValueAssets₹91.127%Over (-91.2%)
EV/EBITDAEnterprise₹207.679%Over (-80%)
Earnings YieldEarnings₹148.407%Over (-85.7%)
ROCE CapitalReturns₹432.529%Over (-58.4%)
Revenue MultipleRevenue₹144.985%Over (-86%)
Consensus (9 models)₹221.28100%Overvalued
Key Drivers: Wide model spread (₹31–₹433) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 1.2%

*Investments are subject to market risks

Investment Snapshot

62
Laurus Labs Ltd scores 62/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health61/100 · Moderate
ROCE 9.5% AverageROE 7.8% AverageD/E 0.50 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money85/100 · Strong
FII holding up 1.01% (6mo) AccumulatingDII holding up 0.64% MF buyingPromoter holding at 27.5% Stable
Earnings Quality40/100 · Moderate
OPM contracting (27% → 17%) Declining
Quarterly Momentum100/100 · Strong
Revenue (4Q): +24% YoY AcceleratingProfit (4Q): +222% YoY StrongOPM: 23.0% (up 7.0% YoY) Margin expansion
Industry Rank35/100 · Weak
P/E 70.0 vs industry 53.8 In-lineROCE 9.5% vs industry 16.4% Below peers3Y sales CAGR: 3% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:14 am

Market Cap 56,080 Cr.
Current Price 1,039
Intrinsic Value₹221.28
High / Low 1,141/517
Stock P/E70.0
Book Value 91.1
Dividend Yield0.12 %
ROCE9.47 %
ROE7.75 %
Face Value 2.00
PEG Ratio56.91

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Laurus Labs Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Laurus Labs Ltd 56,080 Cr. 1,039 1,141/51770.0 91.10.12 %9.47 %7.75 % 2.00
Abbott India Ltd 56,291 Cr. 26,490 37,000/25,35036.9 1,8881.79 %46.2 %35.7 % 10.0
Biocon Ltd 59,196 Cr. 365 425/29572.1 2000.14 %6.25 %4.76 % 5.00
Glenmark Life Sciences Ltd 59,293 Cr. 2,101 2,298/1,33621.9 3400.12 %19.4 %15.8 % 1.00
Glenmark Pharmaceuticals Ltd 59,293 Cr. 2,101 2,298/1,33621.9 3400.12 %19.4 %15.8 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Laurus Labs Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 1,5011,2791,1081,1581,1321,4151,1171,1851,2651,6501,4331,5671,509
Expenses 1,1161,0279809789621,1439561,0031,0591,2551,1051,1771,164
Operating Profit 385252128181170271161182206395327390346
OPM % 26%20%12%16%15%19%14%15%16%24%23%25%23%
Other Income 36761124912772222814
Interest 39413338384241454849443431
Depreciation 78818485878991918988949694
Profit before tax 270137176357164395877330211289234
Tax % 26%25%24%26%25%26%26%27%25%24%25%25%25%
Net Profit 199102134743121294257252158216175
EPS in Rs 3.701.900.240.870.792.250.530.791.064.672.934.003.24

Last Updated: February 5, 2026, 5:41 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 8:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,1601,3261,7751,8922,0272,2362,7974,7694,7075,7734,8125,2176,159
Expenses 9511,1211,4021,4781,6181,8842,2263,2583,4214,2924,0624,2734,701
Operating Profit 2092053724144093525711,5111,2861,4827519441,458
OPM % 18%15%21%22%20%16%20%32%27%26%16%18%24%
Other Income 9344322815526201647100136
Interest 64106111977586886696146151182158
Depreciation 336186104121161184197235301345359372
Profit before tax 121721802452411213041,2759751,0513015041,065
Tax % 20%-2%19%18%28%22%12%25%23%28%26%24%
Net Profit 977414520017395267956750760224380801
EPS in Rs 12.649.4718.363.783.271.785.0017.8213.9614.124.157.0514.84
Dividend Payout % 0%0%2%8%9%17%10%11%14%14%19%17%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-23.71%95.95%37.93%-13.50%-45.09%181.05%258.05%-21.55%1.33%-70.53%69.64%
Change in YoY Net Profit Growth (%)0.00%119.66%-58.01%-51.43%-31.59%226.14%77.00%-279.60%22.88%-71.86%140.17%

Laurus Labs Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:15%
5 Years:13%
3 Years:3%
TTM:15%
Compounded Profit Growth
10 Years:17%
5 Years:5%
3 Years:-23%
TTM:113%
Stock Price CAGR
10 Years:%
5 Years:30%
3 Years:16%
1 Year:79%
Return on Equity
10 Years:16%
5 Years:17%
3 Years:11%
Last Year:8%

Last Updated: September 5, 2025, 9:40 am

Balance Sheet

Last Updated: December 4, 2025, 1:34 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 151616106106106107107107108108108108
Reserves 2816457901,2501,4071,4841,7092,6053,2813,9494,0994,4564,810
Borrowings 6058881,0818089471,0091,0511,4111,6531,7142,1102,3801,821
Other Liabilities 3723443425095477188721,5021,5671,1871,3511,6431,953
Total Liabilities 1,2731,8932,2292,6733,0083,3183,7395,6256,6096,9587,6678,5878,692
Fixed Assets 4998011,0141,1931,4481,5991,6941,8182,1862,8843,0362,8882,946
CWIP 1161077014316310767324755357156336438
Investments 0192651525858319362384635740807
Other Assets 6589661,1191,2861,3451,5541,9203,1643,3063,3333,8414,6234,501
Total Assets 1,2731,8932,2292,6733,0083,3183,7395,6256,6096,9587,6678,5878,692

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 121-59197321369293345694823882659540
Cash from Investing Activity + -312-406-315-282-417-257-217-900-837-735-757-592
Cash from Financing Activity + 20348690-4749-37-12724315-18513959
Net Cash Flow 1221-27-80-00382-39418
Free Cash Flow -185-438-12450-12421279862141293258
CFO/OP 69%-20%62%90%105%90%67%61%77%78%101%71%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-396.00-683.00371.00-394.00-538.00351.00570.000.000.000.00749.00942.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 617891108100112102989894124142
Inventory Days 165210177184199201233257279211258258
Days Payable 1141019111010614415719414090151138
Cash Conversion Cycle 112187177183193169177161237216231262
Working Capital Days -50-0207-79195057675656
ROCE %25%15%17%17%14%8%14%38%23%22%8%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 27.20%27.20%27.20%27.18%27.18%27.18%27.18%27.62%27.62%27.60%27.60%27.49%
FIIs 22.42%22.52%24.03%25.39%25.98%25.67%26.08%25.56%25.51%25.70%26.17%26.52%
DIIs 9.74%10.36%11.01%11.13%11.78%13.56%13.05%12.74%11.78%11.94%11.72%12.42%
Public 40.64%39.93%37.75%36.30%35.07%33.59%33.69%34.09%35.09%34.78%34.52%33.57%
No. of Shareholders 4,18,6154,17,9774,02,6403,82,8803,56,8303,24,0593,09,0632,92,2142,92,9052,80,2232,83,6782,80,756

Shareholding Pattern Chart

No. of Shareholders

Laurus Labs Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Mirae Asset Large & Midcap Fund 8,157,871 1.86 787.236,671,1812026-02-23 01:20:4722.29%
Mirae Asset ELSS Tax Saver Fund 6,091,118 2.25 587.795,023,4662026-02-23 07:21:0921.25%
Mirae Asset Midcap Fund 3,594,526 1.96 346.872,822,5882026-02-23 07:21:0927.35%
SBI Large & Midcap Fund 2,471,231 0.64 238.473,747,8932026-02-23 07:21:09-34.06%
Axis Small Cap Fund 2,117,487 0.8 204.341,589,9772025-12-08 03:11:1333.18%
DSP Healthcare Fund 1,832,618 5.95 176.851,914,4762026-01-25 06:03:53-4.28%
SBI Healthcare Opportunities Fund 1,320,000 3.33 127.381,400,0002026-02-23 05:17:24-5.71%
Tata Arbitrage Fund 1,131,350 0.53 109.181,132,2002026-02-23 07:21:09-0.08%
Mahindra Manulife Multi Cap Fund 1,100,000 1.76 106.151,477,2332025-12-14 01:23:13-25.54%
HSBC Small Cap Fund 1,077,300 0.69 103.96N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 6.652.9814.6915.4218.36
Diluted EPS (Rs.) 6.642.9714.6415.4218.28
Cash EPS (Rs.) 14.5610.2620.8120.1722.16
Book Value[Excl.RevalReserv]/Share (Rs.) 82.9976.2875.1662.5148.47
Book Value[Incl.RevalReserv]/Share (Rs.) 82.9976.2875.1662.5148.47
Revenue From Operations / Share (Rs.) 103.0593.53112.1491.8589.70
PBDIT / Share (Rs.) 20.6914.9129.6726.7229.34
PBIT / Share (Rs.) 12.717.7823.6522.0425.52
PBT / Share (Rs.) 8.994.3920.5920.1724.25
Net Profit / Share (Rs.) 6.583.1214.7915.4918.33
NP After MI And SOA / Share (Rs.) 6.652.9814.6715.4018.33
PBDIT Margin (%) 20.0715.9426.4529.0932.70
PBIT Margin (%) 12.338.3121.0923.9928.44
PBT Margin (%) 8.714.6818.3521.9527.03
Net Profit Margin (%) 6.383.3313.1816.8620.43
NP After MI And SOA Margin (%) 6.453.1813.0816.7620.43
Return on Networth / Equity (%) 8.013.9019.5624.6937.86
Return on Capital Employeed (%) 11.827.9424.3727.6341.57
Return On Assets (%) 3.831.9110.3111.8717.10
Long Term Debt / Equity (X) 0.140.190.180.170.16
Total Debt / Equity (X) 0.600.600.480.510.50
Asset Turnover Ratio (%) 0.620.620.820.761.02
Current Ratio (X) 1.221.231.421.251.25
Quick Ratio (X) 0.670.630.730.590.61
Inventory Turnover Ratio (X) 2.942.861.511.401.95
Dividend Payout Ratio (NP) (%) 12.0353.6713.6010.377.62
Dividend Payout Ratio (CP) (%) 5.4715.809.647.956.31
Earning Retention Ratio (%) 87.9746.3386.4089.6392.38
Cash Earning Retention Ratio (%) 94.5384.2090.3692.0593.69
Interest Coverage Ratio (X) 5.554.399.6814.2623.10
Interest Coverage Ratio (Post Tax) (X) 2.761.925.829.2715.43
Enterprise Value (Cr.) 35759.5823483.3917717.0933370.2920697.57
EV / Net Operating Revenue (X) 6.444.662.936.764.30
EV / EBITDA (X) 32.0729.2111.0923.2413.15
MarketCap / Net Operating Revenue (X) 5.964.192.616.424.04
Retention Ratios (%) 87.9646.3286.3989.6292.37
Price / BV (X) 7.405.143.919.467.48
Price / Net Operating Revenue (X) 5.964.192.616.424.04
EarningsYield 0.010.010.050.020.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 5216.98 Cr. and Equity Capital is Rs. 107.85 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsLaurus Enclave, Plot Office 01, Edulapakabonangi Village, Vishakapatnam Andhra Pradesh 531021Contact not found
Management
NamePosition Held
Dr. Ravindranath KancherlaNon Exe.Chairman&Ind.Director
Mr. V V Ravi KumarExecutive Director & CFO
Dr. Satyanarayana ChavaExecutive Director & CEO
Ms. Soumya ChavaExecutive Director
Dr. C V Lakshmana RaoExecutive Director
Mr. Krishna Chaitanya ChavaExecutive Director
Mrs. Aruna Rajendra BhingeIndependent Director
Mr. Karnam SekarIndependent Director
Dr. Rajesh Koshy ChandyIndependent Director
Mr. Ramesh SubrahmanianIndependent Director

FAQ

What is the intrinsic value of Laurus Labs Ltd and is it undervalued?

As of 19 April 2026, Laurus Labs Ltd's intrinsic value is ₹221.28, which is 78.70% lower than the current market price of ₹1,039.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (7.75 %), book value (₹91.1), dividend yield (0.12 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Laurus Labs Ltd?

Laurus Labs Ltd is trading at ₹1,039.00 as of 19 April 2026, with a FY2026-2027 high of ₹1,141 and low of ₹517. The stock is currently near its 52-week high. Market cap stands at ₹56,080 Cr..

How does Laurus Labs Ltd's P/E ratio compare to its industry?

Laurus Labs Ltd has a P/E ratio of 70.0, which is above the industry average of 53.84. The premium over industry average may reflect growth expectations or speculative interest.

Is Laurus Labs Ltd financially healthy?

Key indicators for Laurus Labs Ltd: ROCE of 9.47 % is on the lower side compared to the industry average of 16.35%; ROE of 7.75 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.12 %.

Is Laurus Labs Ltd profitable and how is the profit trend?

Laurus Labs Ltd reported a net profit of ₹380 Cr in Mar 2025 on revenue of ₹5,217 Cr. Compared to ₹750 Cr in Mar 2022, the net profit shows a declining trend.

Does Laurus Labs Ltd pay dividends?

Laurus Labs Ltd has a dividend yield of 0.12 % at the current price of ₹1,039.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Laurus Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports